Announcements Trials

Browse Landscape

Phase

Phase 2 6 Phase NA 1 Phase 4 1 Phase 3 1

Status

Completed 2 Unknown 1 Recruiting 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Smoking 1 Pulmonary Disease, Chronic Obstructive 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 5 Prednisone 3 Dexamethasone 3 Cisplatin 3 Atorvastatin 3 olaparib 2 lorlatinib 2 human papillomavirus vaccine, L1 type 16, 18 2 enzalutamide 2 adacel 2 Tobacco Use Cessation Devices 2 Tetanus Toxoid 2 Papillomavirus Vaccines 2 Letrozole 2 Diphtheria-Tetanus-acellular Pertussis Vaccines 2 Diphtheria Toxoid 2 Denosumab 2 Carboplatin 2 Anesthesia, Epidural 2 Abiraterone Acetate 2 xiapex 1 venetoclax 1 tirbanibulin 1 tenofovir alafenamide 1 sofosbuvir-velpatasvir drug combination 1 ruxolitinib 1 ribociclib 1 radium Ra 223 dichloride 1 pembrolizumab 1 pasireotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Active not recruiting × Tablets × Clear all

NCT04789057 2026-04-21

Captain

Medical University of Bialystok

Phase 4 Active not recruiting

Smoking, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡